Metformin augments GPRC5D in multiple myeloma and enhances the efficacy of GPRC5D-CAR T cells

被引：0

作者：

Hu, Xiaoli ^{[1
]}

Zhou, Xinyi ^{[1
]}

Zhao, Qian ^{[2
]}

Yang, Ying ^{[1
]}

Liang, Yang ^{[3
]}

Xiao, Yuchen ^{[4
]}

Liu, Zhuoqun ^{[4
]}

Liu, Liu ^{[5
]}

Zhang, Chao ^{[6
]}

Du, Juan ^{[1
]}

机构：

[1] Naval Med Univ, Shanghai Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China

[2] Univ Washington, Dept Mol Biol, Seattle, WA USA

[3] Sun Yat Sen Univ, Dept Hematol Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China

[4] Tongji Univ, Shanghai Yangzhi Rehabil Hosp, Fundamental Res Ctr, Shanghai Sunshine Rehabil Ctr,Sch Med, Shanghai, Peoples R China

[5] Shanghai Yuhui Pharmaceut Technol Grp Co Ltd, Shanghai, Peoples R China

[6] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 205卷 / 05期

基金：

中国国家自然科学基金;

关键词：

RECEPTOR;

D O I：

10.1111/bjh.19739

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2049 / 2052

页数：4

共 50 条

[1] GPRC5D-CAR T cells active in MM
Killock, David
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (12) : 747 - 747
[2] GPRC5D-CAR T cells active in MM
David Killock
Nature Reviews Clinical Oncology, 2022, 19 : 747 - 747
[3] Targeting GPRC5D in multiple myeloma
Elemian, Shatha
Al Hadidi, Samer
EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (05) : 229 - 238
[4] GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
Smith, Eric L.
Harrington, Kim
Staehr, Mette
Masakayan, Reed
Jones, Jon
Long, Thomas J.
Ng, Khong Y.
Ghoddusi, Majid
Purdon, Terence J.
Wang, Xiuyan
Do, Trevor
Minh Thu Pham
Brown, Jessica M.
Fernandez De Larrea, Carlos
Olson, Eric
Peguero, Elizabeth
Wang, Pei
Liu, Hong
Xu, Yiyang
Garrett-Thomson, Sarah C.
Almon, Steven C.
Wendel, Hans-Guido
Rivieres, Isabelle
Liu, Cheng
Sather, Blythe
Brentjens, Renier J.
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (485)
[5] Targeting GPRC5D for multiple myeloma therapy
Zhou, Dian
Wang, Ying
Chen, Chong
Li, Zhenyu
Xu, Kailin
Zhao, Kai
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
[6] Doubling down on GPRC5D in multiple myeloma
Neri, Paola
BLOOD, 2025, 145 (02) : 146 - 148
[7] Safety and Efficacy of GPRC5D CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients
Li, Shiqi
Yuan, Zhongtao
Liu, Lin
Li, Yu
Luo, Le
Chen, Yingnian
Zhang, Lihua
Li, Guangchao
Luo, Min
Zeng, Kaikai
Ma, Donghui
Wang Sanbin, Sr.
BLOOD, 2023, 142
[8] GPRC5D as a novel immunotherapeutic target in multiple myeloma
Karthik Nath
Bruno A. Costa
Sham Mailankody
Nature Reviews Clinical Oncology, 2023, 20 : 281 - 282
[9] GPRC5D as a novel immunotherapeutic target in multiple myeloma
Nath, Karthik
Costa, Bruno A.
Mailankody, Sham
NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (05) : 281 - 282
[10] GPRC5D CAR T-CELL THERAPY HAS ANTITUMOR ACTIVITY IN MULTIPLE MYELOMA
不详
CANCER DISCOVERY, 2019, 9 (06) : 690 - 690

← 1 2 3 4 5 →